+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Coronary Guidewires (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

  • ID: 5134529
  • Report
  • November 2020
  • Region: Global
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abbott Laboratories
  • Asahi Intecc Co Ltd
  • B. Braun Melsungen AG
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • Cardinal Health Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

Coronary Guidewires (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Coronary Guidewires market for the year 2020 and beyond. A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). The guidewire has an elongated body which provides flexibility and a distal tip.

Generally a coronary guidewire has three parts: central core, outer covering and flexible distal tip. The core is made of either stainless steel, dura steel or nitinol. The coating on guidewire may be either hydrophilic or hydrophobic. One unit refers to one coronary guidewire.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Coronary Guidewires market and evolving competitive landscape -
  • Insightful review of the key industry trends.
  • Annualized total Coronary Guidewires market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, the publisher's analysts provide unique country specific insights on the market.
  • SWOT analysis for Coronary Guidewires market.
  • Competitive dynamics insights and trends provided Coronary Guidewires market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Terumo Corp, Boston Scientific Corp, Medtronic plc, B. Braun Melsungen AG, Asahi Intecc Co Ltd, Cardinal Health Inc, Otsuka Holdings Co Ltd, Cook Group Inc, Lepu Medical Technology (Beijing) Co Ltd, Japan Lifeline Co Ltd, Biotronik SE & Co KG and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
  • CMO executives who must have deep understanding of the Coronary Guidewires Systems marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -
  • Understand the impact of COVID-19 on Coronary Guidewires market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Coronary Guidewires market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Coronary Guidewires market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Coronary Guidewires market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Terumo Corp
  • Boston Scientific Corp
  • Medtronic plc
  • B. Braun Melsungen AG
  • Asahi Intecc Co Ltd
  • Cardinal Health Inc
  • Otsuka Holdings Co Ltd
  • Cook Group Inc
  • Lepu Medical Technology (Beijing) Co Ltd
  • Japan Lifeline Co Ltd
  • Biotronik SE & Co KG
Note: Product cover images may vary from those shown